Filing Flows › Radian Group (RDN) › Stock forecast & fair value
Radian Group (RDN) stock forecast and fair value
Radian Group (RDN) trades at $35.97. 7 analysts' median price target is $44.00 (+22%), from $36.00 to $48.00. Across 14 valuation methods the middle fair value is $53.60 (+49%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $36.10 | $49.46 | $61.35 | +37% |
| P/E vs peers, weighted | $51.46 | $61.29 | $79.02 | +70% |
| Residual income | $39.66 | $41.17 | $42.77 | +14% |
| P/B vs ROE (insurer peers) | $18.99 | $70.51 | $122.02 | +96% |
| Analysts' price targets | $36.00 | $42.57 | $48.00 | +18% |
| Shareholder yield (dividends + buybacks) | $66.01 | $77.65 | $94.26 | +116% |
| Justified P/B (Gordon growth) | $55.58 | $68.90 | $90.61 | +92% |
| Dividend discount (Gordon) | $21.78 | $27.00 | $35.52 | -25% |
| Stage-weighted value (financial (bank / insurer)) | $33.89 | $53.60 | $75.26 | +49% |
| Combined forecast (3 months) | $29.45 | $37.39 | $46.33 | +4% |
Radian Group's latest quarter
Radian Group, Q3 2026: revenue $624M (+106% year over year), operating margin 36.6%, net earnings $164M, operating cash flow $380M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for RDN stock?
The median of 7 analysts' 12-month targets is $44.00, +22% from $35.97; the range is $36.00 to $48.00. The average rating is buy.
What is Radian Group's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $25.79 and $77.65, with a middle value of $53.60 against a price of $35.97. Each method's assumptions are on the page.
Does Radian Group usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is RDN stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.